EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines releaseKoung Jin Suh(Seoul National University Bundang Hospital), Jong Seok Lee(Seoul National University Bundang Hospital)OncotargetJuly 12, 201710.18632/oncotarget.19194Cited by 46SaveCiteExport RISWatch citationsRelated PapersAZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)|The Oncologist|2023|19